Author Archives: Pamela Banning

Computerized Physician Order Sets for Meaningful Use – Getting Attention from LOINC and Regenstrief Institute

There’s been a lot of attention on standardizing laboratory order sets in the past year in preparation for the Meaningful Use requirements for computerized physician order sets (CPOE). The Standards & Interoperability (S&I) Framework group known as a LOINC Order Code met for fifteen months. Representatives from the Centers for Disease Control (CDC), Regenstrief Institute and various national reference laboratories and consultants were involved, with 3M as a principal participant. The group took on the scope of examining ambulatory patient laboratory orders. Continue reading

Meaningful Use and Laboratory Data Management: Getting to the Next Level

I am known for having a “glass is half full” optimistic view of life, so when I was recently presented with the opportunity to be a panelist at a Meaningful Use discussion, I accepted. The discussion was held at the American Association for Clinical Chemistry (AACC) 2014 annual meeting in Chicago. This year’s Healthcare Forum session was held jointly with American Society for Clinical Laboratory Scientists (ASCLS). I pondered the best way to adequately portray the complexity (a.k.a. frustration and confusion) occurring across the industry as hospitals attempt to keep up with MU (not to mention all of the other federal mandates). Continue reading